NEXTURN BIO
NEXTURN BIO
Industry:
Biotechnology Health Care Pharmaceutical
Address:
Giheung, Kyonggi-do, South Korea
Country:
South Korea
Status:
Active
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-05-06 | RosVivo Therapeutics | RosVivo Therapeutics acquired by Nexturn Bio | N/A |
More informations about "Nexturn Bio"
Nexturn Bio - Crunchbase Company Profile & Funding
Nexturn Bio is an R&D company for miRNA (MicroRNA) new drugs in Nevada. Where is Nexturn Bio's headquarters? Nexturn Bio is located in Giheung, Kyonggi-do, South Korea. Who are …See details»
Nexturn Bioscience - Crunchbase Company Profile
Nexton Bioscience is a manufacturer of CNC automatic lathes, and has the automatic lathe market, which was monopolized by large companies, with only …See details»
Nexturn Bio - Funding, Financials, Valuation & Investors
Nexturn Bio is an R&D company for miRNA (MicroRNA) new drugs in Nevada.See details»
Nexturn Bio Inc. acquired a 50% stake in RosVivo …
May 30, 2021 · Nexturn Bio Inc. decided to invest in RosVivo and its miRNA technology through due diligence and valuation by industry-leading law firms, patent corporations, strategy consulting firms, and...See details»
The world's first-in-class miRNA therapeutics to cure ... - BioSpace
May 6, 2021 · Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd. (KOSDAQ:89140), has selected its first technological investment target to expand its new bio business.See details»
The world's first-in-class miRNA therapeutics to cure …
May 7, 2021 · Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd. (KOSDAQ:89140), has selected its first technological investment target to expand its new bio business.See details»
Nexturn Bio Inc. acquired a 50% stake in RosVivo ... - BioSpace
May 30, 2021 · Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd., announced on May 26th that it had acquired a 50% stake in RosVivo Therapeutics Inc., an American new drug …See details»
Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc.
Jun 1, 2021 · Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd., announced on May 26th that it had acquired a 50% stake in RosVivo Therapeutics Inc. (“Rosvivo”), an American …See details»
Nexturn Bio Inc. decided to invest in the development of a
May 6, 2021 · Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd. (KOSDAQ:89140), said it has secured a 50% stake in RosVivo Therapeutics Inc., a U.S. new drug developer, as …See details»
Nexturn Bio - Crunchbase
Nexturn Bio is an R&D company for miRNA (MicroRNA) new drugs in Nevada.See details»
Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc.
SEOUL, South Korea, May 30, 2021 /PRNewswire/ -- Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd., announced on May 26th that it had acquired a 50% stake in RosVivo …See details»
Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc.
Feb 22, 2022 · RosVivo's RSVI-301 pipeline is the world's first in class new drug candidate that can fundamentally treat diabetes by restoring the function of beta cells that secrete insulin, the …See details»
Nexturn Bio Inc. decided to invest in the development of a
SEOUL, South Korea, May 7, 2021 /PRNewswire/ -- Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd. (KOSDAQ:89140), said it has secured a 50% stake in RosVivo …See details»
Nexturn Bio Inc. decided to invest in the development of a new …
SEOUL, South Korea, May 6, 2021 /PRNewswire/ -- Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd. (KOSDAQ:89140), said it has secured a 50% stake in RosVivo …See details»
Nexturn Biosciences - CB Insights
May 30, 2021 · As a result, Nexturn Bio Inc. strengthens its capabilities as a bio-company by cooperating in the development of new medication pipelines utilizing miRNA technology to …See details»
Nexturn Bio Inc. decided to invest in the development of a new …
SEOUL, South Korea, May 6, 2021 /PRNewswire/ -- Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd. (KOSDAQ:89140), said it has secured a 50% stake in RosVivo …See details»
The world's first-in-class miRNA therapeutics to cure diabetes by ...
SEOUL, South Korea, May 7, 2021 /PRNewswire/ -- Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd. (KOSDAQ:89140), has selected its first technological investment target to...See details»
Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc.
SEOUL, South Korea, May 30, 2021 /PRNewswire/ -- Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd., announced on May 26th that it had acquired a 50% stake in RosVivo …See details»
The world's first-in-class miRNA therapeutics to cure diabetes by ...
SEOUL, South Korea, May 7, 2021 /PRNewswire/ -- Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd. (KOSDAQ:89140), has selected its first technological investment target to …See details»
RosVivo Therapeutics acquired by Nexturn Bio - Crunchbase
May 6, 2021 · PR Newswire — Nexturn Bio Inc. decided to invest in the development of a new drug pipeline for diabetes treatment using miRNA News • May 6, 2021 The world's first-in …See details»